Loading clinical trials...
Loading clinical trials...
Patients with Latent Autoimmune Diabetes in Adults (LADA) show autoantibodies that indicate an autoimmune pathogenesis. Glutamic acid decarboxylase autoantibodies (GADA) are most prevalent islet autoa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universidad Juárez Autónoma de Tabasco
NCT06967701 · Type 1 Diabetes (T1D), Latent Autoimmune Diabetes in Adult (LADA), and more
NCT06941675 · Latent Autoimmune Diabetes in Adults (LADA)
NCT07460336 · Latent Autoimmune Diabetes in Adults (LADA)
NCT00456027 · Latent Autoimmune Diabetes in Adult (LADA)
Isela Esther Juarez Rojop
Villahermosa, Tabasco
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions